Topline results were announced from a phase 3 trial evaluating Xyngari™ (formerly DMT310), a novel topical treatment derived ...

Dermata's Xyngari showed significant acne improvement in Phase 3 results. A second pivotal trial is set for the second half ...

A limited amount of retail products containing benzoyl peroxide have been voluntarily recalled after testing for possible benzene contamination.

That could include probiotics, both topical and oral. Two recent reviews of studies investigating this possibility suggest ...

A reported 3500 US Food & Drug Administration staff are headed for the guillotine, as part of Trump's broader purge of the health bureaucracy.

Everyone's skin is unique – so it's essential to tailor your beauty routine to your individual needs in summer. Here's a complete guide for every skin type.

Valisure, an independent quality advocate, filed a citizen petition claiming to have detected elevated levels of benzene in ...

Dermata Therapeutics shares jumped more than 50% in early trading Thursday after the biotechnology company said its Xyngari once-weekly, topical product candidate for the treatment of ...

The Food and Drug Administration campus in Silver Spring, Md., is seen, Oct. 14, 2015. WASHINGTON — U.S. health officials are asking retailers to pull a small number of acne creams from their ...

The Company claims the sponge powder exfoliates the skin, promotes collagen production, and opens closed comedones.

Dermata Therapeutics (DRMA) announced positive topline results from the company’s first pivotal Phase 3 trial of xyngari, a novel, once-weekly, ...